Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
De novo lupus nephritis during treatment with belimumab.
Parodis I, Vital EM, Hassan SU, Jönsen A, Bengtsson AA, Eriksson P, Leonard D, Gunnarsson I, Rönnblom L, Sjöwall C. Parodis I, et al. Among authors: gunnarsson i. Rheumatology (Oxford). 2021 Sep 1;60(9):4348-4354. doi: 10.1093/rheumatology/keaa796. Rheumatology (Oxford). 2021. PMID: 33341888 Free PMC article.
Olsalazine-induced lupus syndrome.
Gunnarsson I, Pettersson E, Lindblad S, Ringertz B. Gunnarsson I, et al. Scand J Rheumatol. 1997;26(1):65-6. doi: 10.3109/03009749709065668. Scand J Rheumatol. 1997. PMID: 9057806
Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone.
van Vollenhoven RF, Gunnarsson I, Welin-Henriksson E, Sundelin B, Osterborg A, Jacobson SH, Klareskog L. van Vollenhoven RF, et al. Among authors: gunnarsson i. Scand J Rheumatol. 2004;33(6):423-7. doi: 10.1080/03009740410010227. Scand J Rheumatol. 2004. PMID: 15794203
245 results